10-Q: TILT Holdings Reports Q2 2024 Results Amidst Market Challenges and Strategic Shifts

TILT Holdings experienced a significant revenue decrease in Q2 2024, alongside a substantial impairment loss, while navigating ongoing financial and operational challenges.

Summary

• TILT Holdings reported a net revenue of $26.58 million for the three months ended June 30, 2024, a decrease from $41.6 million in the same period last year.
• The company's gross profit increased slightly to $4.26 million, up from $4.04 million year-over-year, with a gross margin of 16% compared to 10% in the prior year.
• Operating expenses rose to $27.76 million, primarily due to a $15.73 million impairment loss, compared to $17.99 million in the prior year.
• The company's net loss for the quarter was $35.95 million, compared to a net loss of $26.9 million in the same period last year.
• For the six months ended June 30, 2024, net revenue was $64.09 million, down from $83.86 million in the prior year, and the net loss was $45.6 million, compared to a net loss of $31.77 million in the prior year.
• The company's cash and cash equivalents decreased to $1.38 million as of June 30, 2024, from $2.03 million at the end of 2023.
• TILT Holdings has a negative working capital of $34.96 million as of June 30, 2024, compared to negative working capital of $19.8 million as of December 31, 2023.
• The company is negotiating a waiver and forbearance agreement with noteholders due to non-compliance with certain payment obligations and covenants.

Sentiment

Score: 3

Explanation: The document indicates significant financial and operational challenges, including a substantial revenue decline, a large impairment loss, and ongoing liquidity issues. The company's ability to continue as a going concern is in doubt, and it is not in compliance with certain debt obligations. While there are some positive aspects, such as improved gross margin and a new loan, the overall sentiment is negative.

Positives

• Gross margin improved to 16% in Q2 2024, up from 10% in the prior year, due to reduced inventory adjustments.
• The company secured a $10.5 million loan for dispensary construction in Pennsylvania, with an initial draw of $3 million.
• Cost control efforts resulted in lower wages and benefits expense largely due to reduced headcount and lower severance.

Negatives

• Revenue decreased by 36% year-over-year in Q2 2024, primarily due to lower sales volume and price compression in the Jupiter and cannabis divisions.
• The company recorded a significant impairment loss of $15.73 million in Q2 2024, mainly related to its Massachusetts operations.
• The company's net loss increased to $35.95 million in Q2 2024, compared to a net loss of $26.9 million in the same period last year.
• TILT Holdings has a negative working capital of $34.96 million as of June 30, 2024, indicating ongoing liquidity challenges.
• The company is not in compliance with certain payment obligations and covenants under its 2023 Refinanced Notes and 2023 New Notes.

Risks

• The company faces substantial doubt about its ability to continue as a going concern within 12 months.
• The company is not in compliance with certain payment obligations and covenants under its 2023 Refinanced Notes and 2023 New Notes.
• The company's liquidity is constrained by high interest rates on its debt, including default interest rates.
• The company's revenue is impacted by delays in shipping from a primary supplier and lower average prices in certain product lines.
• The Massachusetts market continues to experience challenges marked by increased cultivation and supply, market saturation, and pricing pressure.

Future Outlook

The company's operating plans for the next 12 months include increasing revenue growth, reducing production and supply chain costs, delaying overhead expenditures, obtaining other financings, and deferring principal and interest payments on certain notes. The company believes that successfully implementing these operating plans will help to mitigate any substantial doubt raised by historical operating results and satisfy estimated liquidity needs.

Management Comments

• Management believes that successfully implementing these operating plans will help to mitigate any substantial doubt raised by our historical operating results and satisfy our estimated liquidity needs for the 12 months following the issuance of these condensed consolidated financial statements.
• The Company is currently negotiating a waiver and forbearance agreement with the Note Holders to address such non-compliance.

Industry Context

The cannabis industry is facing increased competition, market saturation, and pricing pressure, particularly in states like Massachusetts. TILT Holdings is navigating these challenges while also dealing with supply chain issues and the need for additional financing.

Comparison to Industry Standards

• The company's revenue decline of 36% year-over-year in Q2 2024 is worse than the average performance of many multi-state operators (MSOs) in the cannabis industry, which have generally seen more modest declines or even growth in some cases.
• The significant impairment loss of $15.73 million in Q2 2024 indicates potential issues with asset valuation and operational performance, which is not typical for all MSOs.
• The company's negative working capital of $34.96 million is a significant concern, as many MSOs are focused on improving their balance sheets and achieving positive cash flow.
• The company's reliance on debt financing and the need for a waiver and forbearance agreement with noteholders is a sign of financial distress, which is not a common situation for all MSOs.
• Compared to companies like Curaleaf, Trulieve, and Green Thumb Industries, which have reported more stable revenue and profitability, TILT Holdings is facing more significant challenges.

Legal Proceedings

• The company is involved in ongoing litigation with Haze Corp., which was dismissed due to lack of personal jurisdiction but is currently under appeal.

Related Party Transactions

• The company has a payable of $23.12 million to Mark Scatterday through Mak One LLP, related to the 2023 Refinanced Notes.
• The company has a payable of $2.33 million to Adam Draizin through Callisto Collaboration, LLC, related to the 2023 Refinanced Notes and 2023 New Notes.

Stakeholder Impact

• Shareholders are negatively impacted by the company's poor financial performance and the substantial doubt about its ability to continue as a going concern.
• Employees may be affected by potential cost-cutting measures and reduced headcount.
• Customers may experience disruptions due to supply chain issues and potential changes in operations.
• Suppliers may face uncertainty due to the company's financial challenges.
• Creditors are at risk due to the company's non-compliance with debt obligations and ongoing liquidity issues.

Next Steps

• The company plans to increase revenue growth from existing and new products.
• The company aims to reduce production and operational costs through efficiencies.
• The company intends to reduce supply chain costs.
• The company plans to reduce and delay overhead and other expenditures.
• The company will seek additional financing as necessary.
• The company will defer principal and interest payments on the 2023 Refinanced Notes.
• The company is negotiating a waiver and forbearance agreement with noteholders.

Key Dates

Keywords

cannabis, vape, dispensary, revenue, impairment, liquidity, debt, Massachusetts, Pennsylvania, operations